HBE Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$415K Sell
2,855
-27
-0.9% -$3.73K 0.3% 36
2026
Q2
$370K Buy
2,882
+17
+0.6% +$1.99K 0.27% 38
2026
Q1
$345K Buy
2,865
+416
+17% +$48K 0.3% 35
2025
Q4
$258K Buy
+2,449
New +$230K 0.24% 38

Other funds holding MRK

HBE Wealth Management's MRK Position: Q3 2026 in Review

HBE Wealth Management reduced its Merck (MRK) stake by 0.94% in Q3 2026, selling an estimated $3.73K and leaving 2,855 shares worth $415K. The position accounts for 0.3% of the portfolio, ranked #36.

HBE Wealth Management first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,975 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • HBE Wealth Management held 2,855 shares of Merck worth $415K as of Q3 2026.
  • HBE Wealth Management sold 27 Merck shares in Q3 2026, an estimated $3.73K.
  • Merck made up 0.3% of HBE Wealth Management's portfolio in Q3 2026, its #36 holding.
  • HBE Wealth Management first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • 3,975 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on HBE Wealth Management's 13F filing for Q3 2026, filed 6 Nov 2026.